期刊文献+

载脂蛋白AI基因多态性与冠心病和血脂关系的研究 被引量:5

Study on the Relationship between ApoAI Gene Promoter Polymorphism and Coronary Heart Disease and Serum Lipid Levels
下载PDF
导出
摘要 目的 :探讨冠心病患者载脂蛋白(apo)AI基因多态性及其对血脂的影响。方法:应用聚合酶链反应对196例正常人和240例冠心病患者apoAI基因启动子多态性进行分析,扩增含apoAI基因启动子 -75bp 和第一内含子 +83bp的DNA片段,限制性内切酶MspI酶切此片段,琼脂糖凝胶电泳分离基因多态性。结果:2组apoAI基因 -75bp 位点均为G/G基因型占优势,但冠心病组中A/A基因型显著低于对照组(P<0.05) ,2组间 -75bp 位点A、G等位基因频率差别无统计学意义。在男性冠心病患者中 ,A/A基因型携带者血清高密度脂蛋白(HDL)水平显著低于G/G基因型携带者(P<0.05)。2组 +83bp 位点中基因型与等位基因频率差别均无统计学意义。结论:apoAI基因启动子( -75bp)MspI酶切位点的突变与冠心病有一定关联,在冠心病男性患者中,A/A基因型携带者与血清HDL的降低有一定相关性。 Objective:To investigate the relationship between Apo AI gene promoter polymorphism and coronary heart disease(CHD)and serum lipid levels in Chinese population.Methods:The restriction fragment polymorphisms(RFLP)at two MspI sites in the5'end at-75bp and+83bp of apolipoprotein AI gene were detected using PCR in240coronary heart disease patients and196healthy subjects from a population of Chinese Han nationality in Tianjin.Results:G/G genotype was the most frequency in CHD and control groups,but the frequency of A/A genotype in CHD group was significantly lower than that in control group(P<0.05).No difference was found in the frequencies of rare A allele for-75bp and rare T allele for+83bp.In CHD group,male subjects with A/A genotype had a lower serum mean concentration of HDL compared with male subjects with genotype G/G(P<0.05).Conclusion:MspI RFLP at-75bp of apo AI gene is associated with coronary heart disease in Chinese population,and the A/A genotype of apo AI gene is associated with the decrease of serum HDL level.
出处 《天津医药》 CAS 北大核心 2004年第6期327-329,共3页 Tianjin Medical Journal
关键词 载脂蛋白AI 基因多态性 冠心病 血脂 coronary disease apolipoprotein A-I genes polymorphism,restriction fragment length polymorphism
  • 相关文献

参考文献9

  • 1Bai H, Saku K, Liu R, et al. Analysis of a new polymorphism in the human apolipoprotein A-I gene: Association with serum lipoprotein levels and coronary heart disease. J Cardiol, 1996,28: 207- 215.
  • 2Paul-Hayase H, Rosseneu M, Robinson D, et al. Polyrnorphisms in the apolipoprotein(apo) AI-C Ⅲ- AIV gene cluster: Detection of genetic variation determining plasma apoAI, aopC Ⅲ and apo A Ⅳ concentration. Hum Genet, 1992, 88:439- 446.
  • 3Duverger N, Kruth H, Emmanue L, et al. Inhibition of atherosclerosis development in cholesterol-fed human apolipop roteinA-I-transgenic rabbits. Circulation, 1996, 94; 713 - 717.
  • 4Patrick B, Florence EJ ,Jean MC, et al. Somatic gene tansfer of human apo AI inhibits atherosclerosis in mouse models. Circulation, 1999, 99:105 - 110.
  • 5Smith JD, Brinton EA, Breslow, et al.Polymorphism in the human apolipoprotein AI gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. J Clin Invest, 1992, 89:1796 - 800.
  • 6Wilson PW, Anderson KN, Harris T, et al.Determinants of change in total cholesterol and HDL-C with age: the Framingham study. J Gerontol, 1994, 49 : M252 - 257.
  • 7Wang XL, Badenhop R, Humphrey KE, et al. New Mspl polymorphism at + 83 bp of the human apolipoprotein AI gene:association with increased circulating high density lipoprotein cholesterol levels. Genet Epodemiol, 1996, 13(1) : 1 - 6.
  • 8Pulkkinen A, Viitanen L, Kareinen A, et al. MspI polymorphism at + 83 bp in intron 1 of the human apolipoprotein AI gene is associated with elevated levels of HDL cholesterol and apolipoprotein AI in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease. Diabetes Care,2000,23(6):791-798.
  • 9Heng CK, Low PS, Saha N. Variations in the promoter region of the apolipoprotein A-I gene influence plasma lipoprotein(a) levels in Asian indian neonates from Singapore. Pediatric Res,2001,49:514 - 518.

同被引文献63

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部